X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11) 11
oncology (9) 9
female (7) 7
index medicus (7) 7
male (6) 6
hematology, oncology and palliative medicine (5) 5
adult (4) 4
cancer (4) 4
gliomas (4) 4
immunohistochemistry (4) 4
medical prognosis (4) 4
meningioma (4) 4
mutation (4) 4
retrospective studies (4) 4
tumors (4) 4
animals (3) 3
brain cancer (3) 3
classification (3) 3
clinical neurology (3) 3
mgmt promoter methylation (3) 3
middle aged (3) 3
neoplasms (3) 3
neuropathology (3) 3
pathology (3) 3
proteins (3) 3
radiation therapy (3) 3
surgery (3) 3
aged (2) 2
analysis (2) 2
antiangiogenesis (2) 2
antineoplastic agents - therapeutic use (2) 2
brain neoplasms - pathology (2) 2
brain tumors (2) 2
cancer and oncology (2) 2
cancer och onkologi (2) 2
cancer therapies (2) 2
care and treatment (2) 2
cell line, tumor (2) 2
clinical medicine (2) 2
clinical trials (2) 2
combined modality therapy (2) 2
diagnosis (2) 2
digestive system diseases (2) 2
dna methylation (2) 2
dna mutational analysis (2) 2
drug therapy (2) 2
edema (2) 2
enzyme-linked immunosorbent assay (2) 2
europe (2) 2
everolimus (2) 2
gastric cancer (2) 2
glioblastoma - pathology (2) 2
glioblastoma multiforme (2) 2
hypermethylation (2) 2
kinases (2) 2
klinisk medicin (2) 2
magnetic resonance imaging (2) 2
malignant glioma (2) 2
medical and health sciences (2) 2
medical colleges (2) 2
medical diagnosis (2) 2
medical imaging (2) 2
medicin och hälsovetenskap (2) 2
meningeal neoplasms - pathology (2) 2
meningioma - pathology (2) 2
metastasis (2) 2
mice (2) 2
mice, nude (2) 2
mtor (2) 2
neoplasm recurrence, local - pathology (2) 2
palliative care (2) 2
patients (2) 2
phase-ii (2) 2
prognosis (2) 2
radiotherapy (2) 2
recurrent glioblastoma (2) 2
renal-cell carcinoma (2) 2
research article (2) 2
review (2) 2
sirolimus - analogs & derivatives (2) 2
stomach neoplasms - drug therapy (2) 2
stomach neoplasms - pathology (2) 2
studies (2) 2
survival analysis (2) 2
task forces (2) 2
term-follow-up (2) 2
tyrosine kinase inhibitor (2) 2
vascular endothelial growth factor a - biosynthesis (2) 2
vegf (2) 2
1506 (1) 1
1507 (1) 1
610 medicine & health (1) 1
830"1945/" (1) 1
830:82.044 (1) 1
adjuvant radiotherapy (1) 1
adolescent (1) 1
advanced colorectal-cancer (1) 1
age (1) 1
amino-acid pet (1) 1
anaplastic glioma (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 5, pp. 682 - 694
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 6, pp. e315 - e329
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 7, pp. e322 - e332
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 9, pp. e383 - e391
Journal Article
memo - Magazine of European Medical Oncology, ISSN 1865-5041, 2/2017, Volume 10, Issue 1, pp. 18 - 21
For neuro-oncologists, much was accomplished in the last decade, including the establishment of the first standard of care (SOC) in this field of oncology. New... 
IDH1 mutation | CNS4 | Medicine & Public Health | Anaplastic glioma | Oncology | Updated WHO classification of central nervous system tumors | Diffuse glioma | Medicine/Public Health, general | Glioblastoma multiforme | Meningioma | Medicine, Experimental | Medical colleges | Medical research | Gliomas | Cancer | Short Review
Journal Article
Cancer Letters, ISSN 0304-3835, 2010, Volume 296, Issue 2, pp. 249 - 256
Journal Article
Clinical Neuropathology, ISSN 0722-5091, 09/2012, Volume 31, Issue 5, pp. 352 - 360
Journal Article
Cancer Biology & Therapy, ISSN 1538-4047, 06/2010, Volume 9, Issue 11, pp. 919 - 927
The vascular endothelial growth factor (VEGF) is a central mediator of tumor-induced angiogenesis. Everolimus, a mammalian target of rapamycin (mTOR)... 
Binding | Proteins | Landes | Calcium | Bioscience | Biology | Cell | Cycle | Cancer | Organogenesis | Animal model | Antiangiogenesis | VEGF | mTOR | Everolimus | Gastric cancer | Vatalanib | gastric cancer | PTK787/ZK-222584 PTK/ZK | THROMBOTIC MICROANGIOPATHY | RENAL-CELL CARCINOMA | vatalanib | ADVANCED COLORECTAL-CANCER | PHASE-III TRIAL | LIVER METASTASES | ANTIANGIOGENIC THERAPY | everolimus | ONCOLOGY | GASTRIC-CANCER | TYROSINE KINASE INHIBITOR | animal model | antiangiogenesis | VEGF RECEPTOR INHIBITOR | TOR Serine-Threonine Kinases - metabolism | Apoptosis - drug effects | Humans | Stomach Neoplasms - metabolism | Stomach Neoplasms - pathology | Vascular Endothelial Growth Factor A - metabolism | TOR Serine-Threonine Kinases - antagonists & inhibitors | Receptors, Vascular Endothelial Growth Factor - metabolism | Neovascularization, Pathologic - prevention & control | Immunosuppressive Agents - pharmacology | Sirolimus - analogs & derivatives | Phthalazines - administration & dosage | Pyridines - administration & dosage | Enzyme-Linked Immunosorbent Assay | Vascular Endothelial Growth Factor A - blood | Stomach Neoplasms - drug therapy | Sirolimus - pharmacology | Drug Synergism | Xenograft Model Antitumor Assays | Phthalazines - pharmacology | Protein Kinase Inhibitors - administration & dosage | Sirolimus - administration & dosage | Animals | Signal Transduction - drug effects | Tumor Burden - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mice, Nude | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Neovascularization, Pathologic - metabolism | Protein Kinase Inhibitors - pharmacology | Pyridines - pharmacology
Journal Article